Category: Baxano Surgical
Here's a look at some of the top Wall Street stories for medical device companies this week: TriVascular Tech's stent graft recall could hurt the bottom line; Alere unveils $3.82B privatization plan; Medtronic, Covidien slide on new U.S. inversion rules; Baxano puts itself on the auction block; Philips to carve out lighting biz, merger healthcare & consumer units
Baxano Surgical said it's hired an investment advisor to explore "strategic alternatives," corporate shorthand for putting itself on the auction block.
Here's a look at some of the top Wall Street stories for medical device companies this week: FTC wants more data on Medtronic-Covidien deal, but analysts aren't worried; Greatbatch acquires Uruguay's CCC Medical Devices; T2 Biosystems IPO raises $57M for MRI-based diagnostics; Strong Q4, $750M buyback give CareFusion a boost; Baxano: Strong Q2, new patents can't appease Wall Street
Baxano's stock drops 25% after the company reports a 20% increase in sales during its 2nd quarter and the issuance of 2 new patents covering its minimally invasive spinal devices.
Baxano Surgical (NSDQ:BAXS) just can't seem to do right by Wall Street.
Here's a look at some of the top funding stories for medical device companies this week.
Baxano Surgical puts a ribbon on a private placement funding round after raising $10 million from unnamed investors.
SafeStitch Medical lures Joseph Slattery to be its new CFO from Baxano, who names former Talecris Biotherapeutics exec Timothy Shannon as interim replacement.